More recently, they showed that increased PTPN13 expression characterizes CD133+ colon cancer stem cells and that PTPN13 upregulation in metastases, compared with primary tumors or after platinum-based chemotherapy, is due to the relative abundance of these cancer stem cells in the tumor [51]. This evidence concerns the gene PROM1 and malignant colon neoplasm.